Leo Pharma’s Enstiloom acquires approval as psoriasis treatment in Korea
On the 16th, Leo Pharma Korea(President Kasper Kunzel) announced Enstiloom(generic name: calcipotriol/betamethasone dipropionate 50 micrograms/g / 0.643 mg/g), an external aerosol-form-type psoriasis treatment was recently approved to use in Korea.
Psoriasis vulgaris is the most common clinical ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
